PUBLISHER: Grand View Research | PRODUCT CODE: 1611037
PUBLISHER: Grand View Research | PRODUCT CODE: 1611037
The global cell culture media storage containers market size is anticipated to reach USD 4.26 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.55% from 2025 to 2030. Cell culture media storage containers are equipment or vessels built exclusively for storing cell culture media. The cell culture media containers have been developed to meet the unique needs of cell culture, for example maintaining a sterile environment, reducing evaporation, and protecting against light and temperature variations. Increasing R&D efforts, rising demand for biopharmaceuticals, and technical advances in the industry are propelling market expansion. The expansion and growth of the biologics sector will also be a major growth factor for market development.
The COVID-19 pandemic is predicted to have a substantial influence on the cell culture media storage containers industry due to rising vaccine & biologics demand. These are essential in the manufacturing of vaccines and protein-based drugs. The storage bags are widely employed in the creation and testing of vaccine candidates. As a result, the COVID-19 pandemic has had a beneficial impact on the global industry, contributing to its expansion.
One of the key factors is the rising demand for biopharmaceuticals, which has resulted in the widespread adoption of single-use technologies such as single-use storage bottles, bags, bins, and other containers. Disposable products can lower the probability of contamination yet simplify the maintenance and validation process, providing a dependable and cost-effective alternative for biopharmaceutical businesses growing their production capacities.
Furthermore, important factors such as increased research & development spending by biopharmaceutical businesses for novel medicines are likely to have a substantial impact on market growth. According to figures provided by the Organization for Economic Cooperation and Development (OECD) in 2020, the pharmaceutical industry in OECD countries spent over USD 101 billion on research and development. According to the same source, global R&D investment by the largest publicly traded corporations increased by 13.7% year on year. As a result, the biopharmaceutical industry's increased investment in R&D to enhance their product pipelines is likely to drive market expansion in the studied area.